| Host: |
Rabbit |
| Applications: |
IHC/WB |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-SEC22C (C-Term) is suitable for use in Immunohistochemistry and Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Lyophilised |
| Purification: |
IgG purified |
| Dilution Range: |
IHC, WB. A dilution of 1:300 to 1:2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications. |
| Storage Instruction: |
Maintain the lyophilised/reconstituted antibodies frozen at-20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, Glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles. |
| Gene Symbol: |
SEC22C |
| Gene ID: |
9117 |
| Uniprot ID: |
SC22C_HUMAN |
| Immunogen Region: |
C-Term |
| Specificity: |
Specific for SEC22C. |
| Immunogen: |
A synthetic from the c-terminal of human SEC22C conjugated to an immunogenic carrier protein was used as the antigen. The antigen is homologous in mouse and shares 95% identity with rat sequence. |
| Function | May be involved in vesicle transport between the ER and the Golgi complex. |
| Protein Name | Vesicle-Trafficking Protein Sec22cSec22 Vesicle-Trafficking Protein Homolog CSec22 Vesicle-Trafficking Protein-Like 3 |
| Database Links | Reactome: R-HSA-204005 |
| Cellular Localisation | Endoplasmic Reticulum MembraneMulti-Pass Membrane Protein |
| Alternative Antibody Names | Anti-Vesicle-Trafficking Protein Sec22c antibodyAnti-Sec22 Vesicle-Trafficking Protein Homolog C antibodyAnti-Sec22 Vesicle-Trafficking Protein-Like 3 antibodyAnti-SEC22C antibodyAnti-SEC22L3 antibodyAnti-UNQ459 antibodyAnti-PRO784 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
